| Attribute |
Value |
| 52 Week Change |
-0.6947675 |
| Address1 |
501 E. Las Olas Blvd. |
| Address2 |
Suite 300 |
| All Time High |
2,400.0 |
| All Time Low |
0.72 |
| Ask |
3.36 |
| Ask Size |
1 |
| Audit Risk |
10 |
| Average Daily Volume10 Day |
436,570 |
| Average Daily Volume3 Month |
850,895 |
| Average Volume |
850,895 |
| Average Volume10Days |
436,570 |
| Beta |
-0.87 |
| Bid |
2.56 |
| Bid Size |
1 |
| Board Risk |
9 |
| Book Value |
0.262 |
| City |
Fort Lauderdale |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
8 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
2.965 |
| Current Ratio |
0.771 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
4.27 |
| Day Low |
1.51 |
| Display Name |
Alaunos Therapeutics |
| Dividend Yield |
0.0 |
| Earnings Timestamp End |
1,755,201,600 |
| Earnings Timestamp Start |
1,755,201,600 |
| Ebitda |
-4,034,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-0.631 |
| Enterprise To Revenue |
847.835 |
| Enterprise Value |
2,543,504 |
| Eps Forward |
-0.6 |
| Eps Trailing Twelve Months |
-1.76 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
1.4894 |
| Fifty Day Average Change |
1.4755999 |
| Fifty Day Average Change Percent |
0.9907344 |
| Fifty Two Week Change Percent |
-69.476746 |
| Fifty Two Week High |
4.5 |
| Fifty Two Week High Change |
-1.5350001 |
| Fifty Two Week High Change Percent |
-0.34111112 |
| Fifty Two Week Low |
0.72 |
| Fifty Two Week Low Change |
2.245 |
| Fifty Two Week Low Change Percent |
3.1180553 |
| Fifty Two Week Range |
0.72 - 4.5 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,124,890,200,000 |
| Float Shares |
1,891,413 |
| Forward Eps |
-0.6 |
| Forward P E |
-4.941666 |
| Free Cashflow |
-1,570,625 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
1 |
| Fullday Change |
1.915 |
| Fullday Change Percent |
182.38097 |
| Fullday Price |
2.965 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,790,812,800 |
| Gross Margins |
0.0 |
| Gross Profits |
-1,643,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.16318001 |
| Held Percent Institutions |
0.04227 |
| Implied Shares Outstanding |
2,927,135 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ir Website |
http://ir.ziopharm.com/index.cfm |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,721,260,800 |
| Last Split Factor |
1:10 |
| Long Business Summary |
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida. |
| Long Name |
Alaunos Therapeutics, Inc. |
| Market |
us_market |
| Market Cap |
8,678,955 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_11686323 |
| Most Recent Quarter |
1,782,777,600 |
| Name Change Date |
2,026-10-13 |
| Net Income To Common |
-4,116,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
2,997,766 |
| Open |
1.74 |
| Operating Cashflow |
-2,727,000 |
| Operating Margins |
-1,352.3333 |
| Overall Risk |
8 |
| Payout Ratio |
0.0 |
| Peg Ratio |
0.58 |
| Phone |
346 355 4099 |
| Prev Name |
ZIOPHARM Oncology, Inc. |
| Previous Close |
1.05 |
| Price Hint |
4 |
| Price To Book |
11.316793 |
| Price To Sales Trailing12 Months |
2,892.985 |
| Profit Margins |
0.0 |
| Quick Ratio |
0.144 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
1.915 |
| Regular Market Change Percent |
182.38097 |
| Regular Market Day High |
4.32 |
| Regular Market Day Low |
1.51 |
| Regular Market Day Range |
1.51 - 4.32 |
| Regular Market Open |
1.74 |
| Regular Market Previous Close |
1.05 |
| Regular Market Price |
2.965 |
| Regular Market Time |
1,791,915,429 |
| Regular Market Volume |
218,074,592 |
| Return On Assets |
-0.81127 |
| Return On Equity |
-1.85949 |
| Revenue Per Share |
0.001 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
3 |
| Shares Outstanding |
2,927,135 |
| Shares Percent Shares Out |
0.0033000002 |
| Shares Short |
9,736 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
5,707 |
| Short Name |
Alaunos Therapeutics, Inc. |
| Short Percent Of Float |
0.0036000002 |
| Short Ratio |
0.0 |
| Source Interval |
15 |
| State |
FL |
| Symbol |
TCRT |
| Total Cash |
124,000 |
| Total Cash Per Share |
0.049 |
| Total Debt |
0 |
| Total Revenue |
3,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.76 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
2.3828 |
| Two Hundred Day Average Change |
0.5821998 |
| Two Hundred Day Average Change Percent |
0.24433431 |
| Type Disp |
Equity |
| Volume |
218,074,592 |
| Website |
https://www.alaunos.com |
| Zip |
33,301 |